Livia Project
Not Specified
R&DActive
Key Facts
About Neurosonics Medical
Neurosonics Medical is a Paris-based, private company offering high-level electronics design and consulting services specifically for innovative medical devices in neuroscience and bioelectronics. Leveraging its founder's deep network and expertise, the company supports external partners and hosts its own internal R&D projects, such as the Livia Project, in areas like neuroprosthetics and bioinspired technologies. Operating as a service provider and project incubator, Neurosonics is in an early-revenue stage, aiming to build autonomy and expand its technical capabilities into acoustic systems.
View full company profileTherapeutic Areas
Other Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |